Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases

被引：2
|
作者：
Kapoor, Anil [1 ]
Wong, Nathan C. [1 ]
Wang, Yuding [1 ]
Mukherjee, Som [2 ]
Hotte, Sebastien [2 ]
Dayes, Ian [2 ]
Lukka, Himu [2 ]
机构：
[1] McMaster Univ, Div Urol, Dept Surg, Hamilton, ON L8N 4A6, Canada
[2] McMaster Univ, Dept Oncol, Hamilton, ON L8N 4A6, Canada
来源：
ASIAN JOURNAL OF ANDROLOGY | 2020年 / 22卷 / 04期
关键词：
MECHANISMS;
D O I：
10.4103/aja.aja_66_19
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：437 / 438
页数：2
相关论文
共 50 条
  • [1] Bone scintigraphy to evaluate response to therapy with Radium-223 for castration-resistant prostate cancer patients with bone metastases: a single-center experience
    Martinez Albero, E.
    Gomez Grande, A.
    Saviatto Nardi, A.
    Galiana Moron, A.
    Vega Perez, D.
    Godigna Guilloteau, V.
    Pilkington Woll, J.
    Ruiz Solis, S.
    Sarandeses Fernandez, P.
    Tabuenca Mateo, M.
    Estenoz Alfaro, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S696 - S696
  • [2] Treatment of patients with castration-resistant prostate cancer and bone metastases with radium-223: A single institution experience
    Devarakonda, Srinivas S.
    Skweres, Justin
    Nair, Binu Sivaraman
    Dhawan, Manish
    Takalkar, Amol
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why
    Gallicchio, Rosj
    Mastrangelo, Pietro A.
    Nardelli, Anna
    Mainenti, Pier Paolo
    Colasurdo, Antonio P.
    Landriscina, Matteo
    Guglielmi, Giuseppe
    Storto, Giovanni
    TUMORI JOURNAL, 2019, 105 (05): : 367 - 377
  • [4] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
    Vogelzang, Nicholas J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
  • [5] Clinical experience of using the radium-223 in patients with bone metastasis of castration-resistant prostate cancer
    Yurmazov, Z. A.
    Usynin, E. A.
    Medvedeva, A. A.
    Polyakov, A. A.
    Lushnikova, N. A.
    Chernov, V., I
    Spirina, L., V
    ONKOUROLOGIYA, 2022, 18 (01): : 70 - 76
  • [6] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Hiroji Uemura
    Hirotsugu Uemura
    Nobuaki Matsubara
    Seigo Kinuya
    Makoto Hosono
    Yoko Yajima
    Toshihiko Doi
    International Journal of Clinical Oncology, 2017, 22 : 954 - 963
  • [7] Efficacy and Safety of Radium-223 Dichloride in the Treatment of Patients with Castration-Resistant Prostate Cancer with Bone Metastases
    Sanchez Lopez, Hector
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 1 - 2
  • [8] Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review
    Cursano, M. C.
    Iuliani, M.
    Casadei, C.
    Stellato, M.
    Tonini, G.
    Paganelli, G.
    Santini, D.
    De Giorgi, U.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 146
  • [9] Efficacy and tolerance of radium-223 dichloride in patients treated for castration-resistant prostate cancer with bone metastases
    Awoudou, C.
    Bathily, E. H. A. L.
    Djigo, M. S.
    Ndong, B.
    Mbodj, M.
    Paulus, P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2024, 48 (03): : 150 - 157
  • [10] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Uemura, Hiroji
    Uemura, Hirotsugu
    Matsubara, Nobuaki
    Kinuya, Seigo
    Hosono, Makoto
    Yajima, Yoko
    Doi, Toshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (05) : 954 - 963
12345